4.8 Article

Targeting TGF-β for treatment of osteogenesis imperfecta

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Receptor binding competition: A paradigm for regulating TGF-β family action

Erik Martinez-Hackert et al.

Summary: The TGF-beta family is a group of structurally related, multifunctional growth factors crucially involved in the development, regulation, and maintenance of animal tissues. These ligands exhibit promiscuity and compete with each other for binding to receptors, possibly allowing cells to process multiple ligand inputs for subtle, distinctive, or adaptive responses and developmental plasticity. This concept of ligand competition may be fundamentally tied to human physiology, disease, and therapy.

CYTOKINE & GROWTH FACTOR REVIEWS (2021)

Article Endocrinology & Metabolism

Inhibition of TGF-β Increases Bone Volume and Strength in a Mouse Model of Osteogenesis Imperfecta

Benjamin Greene et al.

Summary: Inhibition of the TGF-beta pathway corrects the high-turnover aspects of bone disease and improves biomechanical properties of OI mice, showing both dose and frequency dependency.

JBMR PLUS (2021)

Review Pediatrics

Osteogenesis imperfecta: advancements in genetics and treatment

Vittoria Rossi et al.

CURRENT OPINION IN PEDIATRICS (2019)

Review Pharmacology & Pharmacy

Genetic approaches to metabolic bone diseases

Fadil M. Hannan et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)

Article Endocrinology & Metabolism

Effect of Anti-TGF-β Treatment in a Mouse Model of Severe Osteogenesis Imperfecta

Josephine T. Tauer et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2019)

Review Orthopedics

Current concepts in osteogenesis imperfecta: bone structure, biomechanics and medical management

W. H. Nijhuis et al.

JOURNAL OF CHILDRENS ORTHOPAEDICS (2019)

Article Oncology

Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer

Silvia C. Formenti et al.

CLINICAL CANCER RESEARCH (2018)

Article Genetics & Heredity

A multicenter study to evaluate pulmonary function in osteogenesis imperfecta

Allison Tam et al.

CLINICAL GENETICS (2018)

Article Endocrinology & Metabolism

BPS804 Anti-Sclerostin Antibody in Adults With Moderate Osteogenesis Imperfecta: Results of a Randomized Phase 2a Trial

Francis H. Glorieux et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2017)

Article Medicine, General & Internal

Osteogenesis imperfecta

Joan C. Marini et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

Article Endocrinology & Metabolism

Genetic causes and mechanisms of Osteogenesis Imperfecta

Joohyun Lim et al.

Review Genetics & Heredity

Pharmacological and biological therapeutic strategies for osteogenesis imperfecta

Ronit Marom et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2016)

Review Rheumatology

Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis

Bente Langdahl et al.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2016)

Article Medicine, Research & Experimental

Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients

Lisa M. Rice et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

Article Orthopedics

Behavior of Scoliosis During Growth in Children with Osteogenesis Imperfecta

Alireza K. Anissipour et al.

JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2014)

Article Medicine, Research & Experimental

Evaluation of teriparatide treatment in adults with osteogenesis imperfecta

Eric S. Orwoll et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Article Biochemistry & Molecular Biology

Excessive transforming growth factor-β signaling is a common mechanism in osteogenesis imperfecta

Ingo Grafel et al.

NATURE MEDICINE (2014)

Review Medicine, General & Internal

Bisphosphonate therapy for osteogenesis imperfecta

Kerry Dwan et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)

Article Endocrinology & Metabolism

Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I

Davide Gatti et al.

CALCIFIED TISSUE INTERNATIONAL (2013)

Article Medicine, General & Internal

Osteoporosis: now and the future

Tilman D. Rachner et al.

LANCET (2011)

Article Obstetrics & Gynecology

Characterising and treating osteogenesis imperfecta

Nick Bishop

EARLY HUMAN DEVELOPMENT (2010)

Article Endocrinology & Metabolism

Risedronate in the Treatment of Mild Pediatric Osteogenesis Imperfecta: A Randomized Placebo-Controlled Study

Frank Rauch et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2009)

Article Endocrinology & Metabolism

Two-year clinical trial of oral alendronate versus intravenous pamidronate in children with osteogenesis imperfecta

LA DiMeglio et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2006)

Article Multidisciplinary Sciences

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

A Subramanian et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Endocrinology & Metabolism

Intravenous neridronate in children with osteogenesis imperfecta:: A randomized controlled study

D Gatti et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2005)

Article Endocrinology & Metabolism

Intravenous neridronate in adults with osteogenesis imperfecta

S Adami et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2003)